カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のブメタニド市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Bumetanide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19199）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19199
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のブメタニド市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ブメタニド市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のブメタニドの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ブメタニド市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・内服薬、注射薬

用途別セグメントは次のように区分されます。
・病院、ドラッグストア

世界のブメタニド市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Teva、Zydus Pharmaceuticals、Validus Pharmaceuticals、Upsher-Smith、Guilin Nanyao Company、Eisai、Liaoning Yuhuang Pharmaceutical、Amneal、Sandoz

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ブメタニド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なブメタニドメーカーの企業概要、2019年～2022年までのブメタニドの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なブメタニドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ブメタニドの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのブメタニドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのブメタニド市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびブメタニドの産業チェーンを掲載しています。
・第13、14、15章では、ブメタニドの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ブメタニドの概要
- 種類別分析（2017年vs2021年vs2028年）：内服薬、注射薬
- 用途別分析（2017年vs2021年vs2028年）：病院、ドラッグストア
- 世界のブメタニド市場規模・予測
- 世界のブメタニド生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、Teva、Zydus Pharmaceuticals、Validus Pharmaceuticals、Upsher-Smith、Guilin Nanyao Company、Eisai、Liaoning Yuhuang Pharmaceutical、Amneal、Sandoz
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：内服薬、注射薬
・用途別分析2017年-2028年：病院、ドラッグストア
・ブメタニドの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ブメタニドのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ブメタニドのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ブメタニドの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ブメタニドの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Bumetanide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bumetanide market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Bumetanide global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Bumetanide include Pfizer, Teva, Zydus Pharmaceuticals, Validus Pharmaceuticals, and Upsher-Smith, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bumetanide market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Drugs
Injection Drugs
Market segment by Application can be divided into
Hospital
Drug Store
The key market players for global Bumetanide market are listed below:
Pfizer
Teva
Zydus Pharmaceuticals
Validus Pharmaceuticals
Upsher-Smith
Guilin Nanyao Company
Eisai
Liaoning Yuhuang Pharmaceutical
Amneal
Sandoz
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bumetanide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bumetanide, with price, sales, revenue and global market share of Bumetanide from 2019 to 2022.
Chapter 3, the Bumetanide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bumetanide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Bumetanide market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bumetanide.
Chapter 13, 14, and 15, to describe Bumetanide sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Bumetanide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bumetanide Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral Drugs
1.2.3 Injection Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Bumetanide Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Bumetanide Market Size & Forecast
1.4.1 Global Bumetanide Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Bumetanide Sales in Volume (2017-2028)
1.4.3 Global Bumetanide Price (2017-2028)
1.5 Global Bumetanide Production Capacity Analysis
1.5.1 Global Bumetanide Total Production Capacity (2017-2028)
1.5.2 Global Bumetanide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bumetanide Market Drivers
1.6.2 Bumetanide Market Restraints
1.6.3 Bumetanide Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Bumetanide Product and Services
2.1.4 Pfizer Bumetanide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Bumetanide Product and Services
2.2.4 Teva Bumetanide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Zydus Pharmaceuticals
2.3.1 Zydus Pharmaceuticals Details
2.3.2 Zydus Pharmaceuticals Major Business
2.3.3 Zydus Pharmaceuticals Bumetanide Product and Services
2.3.4 Zydus Pharmaceuticals Bumetanide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Validus Pharmaceuticals
2.4.1 Validus Pharmaceuticals Details
2.4.2 Validus Pharmaceuticals Major Business
2.4.3 Validus Pharmaceuticals Bumetanide Product and Services
2.4.4 Validus Pharmaceuticals Bumetanide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Upsher-Smith
2.5.1 Upsher-Smith Details
2.5.2 Upsher-Smith Major Business
2.5.3 Upsher-Smith Bumetanide Product and Services
2.5.4 Upsher-Smith Bumetanide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Guilin Nanyao Company
2.6.1 Guilin Nanyao Company Details
2.6.2 Guilin Nanyao Company Major Business
2.6.3 Guilin Nanyao Company Bumetanide Product and Services
2.6.4 Guilin Nanyao Company Bumetanide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Eisai
2.7.1 Eisai Details
2.7.2 Eisai Major Business
2.7.3 Eisai Bumetanide Product and Services
2.7.4 Eisai Bumetanide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Liaoning Yuhuang Pharmaceutical
2.8.1 Liaoning Yuhuang Pharmaceutical Details
2.8.2 Liaoning Yuhuang Pharmaceutical Major Business
2.8.3 Liaoning Yuhuang Pharmaceutical Bumetanide Product and Services
2.8.4 Liaoning Yuhuang Pharmaceutical Bumetanide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Amneal
2.9.1 Amneal Details
2.9.2 Amneal Major Business
2.9.3 Amneal Bumetanide Product and Services
2.9.4 Amneal Bumetanide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Sandoz
2.10.1 Sandoz Details
2.10.2 Sandoz Major Business
2.10.3 Sandoz Bumetanide Product and Services
2.10.4 Sandoz Bumetanide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Bumetanide Breakdown Data by Manufacturer
3.1 Global Bumetanide Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Bumetanide Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Bumetanide
3.4 Market Concentration Rate
3.4.1 Top 3 Bumetanide Manufacturer Market Share in 2021
3.4.2 Top 6 Bumetanide Manufacturer Market Share in 2021
3.5 Global Bumetanide Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Bumetanide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bumetanide Market Size by Region
4.1.1 Global Bumetanide Sales in Volume by Region (2017-2028)
4.1.2 Global Bumetanide Revenue by Region (2017-2028)
4.2 North America Bumetanide Revenue (2017-2028)
4.3 Europe Bumetanide Revenue (2017-2028)
4.4 Asia-Pacific Bumetanide Revenue (2017-2028)
4.5 South America Bumetanide Revenue (2017-2028)
4.6 Middle East and Africa Bumetanide Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Bumetanide Sales in Volume by Type (2017-2028)
5.2 Global Bumetanide Revenue by Type (2017-2028)
5.3 Global Bumetanide Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Bumetanide Sales in Volume by Application (2017-2028)
6.2 Global Bumetanide Revenue by Application (2017-2028)
6.3 Global Bumetanide Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Bumetanide Sales by Type (2017-2028)
7.2 North America Bumetanide Sales by Application (2017-2028)
7.3 North America Bumetanide Market Size by Country
7.3.1 North America Bumetanide Sales in Volume by Country (2017-2028)
7.3.2 North America Bumetanide Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Bumetanide Sales by Type (2017-2028)
8.2 Europe Bumetanide Sales by Application (2017-2028)
8.3 Europe Bumetanide Market Size by Country
8.3.1 Europe Bumetanide Sales in Volume by Country (2017-2028)
8.3.2 Europe Bumetanide Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Bumetanide Sales by Type (2017-2028)
9.2 Asia-Pacific Bumetanide Sales by Application (2017-2028)
9.3 Asia-Pacific Bumetanide Market Size by Region
9.3.1 Asia-Pacific Bumetanide Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Bumetanide Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Bumetanide Sales by Type (2017-2028)
10.2 South America Bumetanide Sales by Application (2017-2028)
10.3 South America Bumetanide Market Size by Country
10.3.1 South America Bumetanide Sales in Volume by Country (2017-2028)
10.3.2 South America Bumetanide Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bumetanide Sales by Type (2017-2028)
11.2 Middle East & Africa Bumetanide Sales by Application (2017-2028)
11.3 Middle East & Africa Bumetanide Market Size by Country
11.3.1 Middle East & Africa Bumetanide Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Bumetanide Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Bumetanide and Key Manufacturers
12.2 Manufacturing Costs Percentage of Bumetanide
12.3 Bumetanide Production Process
12.4 Bumetanide Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Bumetanide Typical Distributors
13.3 Bumetanide Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Bumetanide Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Bumetanide Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Bumetanide Product and Services
Table 6. Pfizer Bumetanide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Bumetanide Product and Services
Table 10. Teva Bumetanide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Zydus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Zydus Pharmaceuticals Major Business
Table 13. Zydus Pharmaceuticals Bumetanide Product and Services
Table 14. Zydus Pharmaceuticals Bumetanide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Validus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Validus Pharmaceuticals Major Business
Table 17. Validus Pharmaceuticals Bumetanide Product and Services
Table 18. Validus Pharmaceuticals Bumetanide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Upsher-Smith Basic Information, Manufacturing Base and Competitors
Table 20. Upsher-Smith Major Business
Table 21. Upsher-Smith Bumetanide Product and Services
Table 22. Upsher-Smith Bumetanide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Guilin Nanyao Company Basic Information, Manufacturing Base and Competitors
Table 24. Guilin Nanyao Company Major Business
Table 25. Guilin Nanyao Company Bumetanide Product and Services
Table 26. Guilin Nanyao Company Bumetanide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Eisai Basic Information, Manufacturing Base and Competitors
Table 28. Eisai Major Business
Table 29. Eisai Bumetanide Product and Services
Table 30. Eisai Bumetanide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Liaoning Yuhuang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Liaoning Yuhuang Pharmaceutical Major Business
Table 33. Liaoning Yuhuang Pharmaceutical Bumetanide Product and Services
Table 34. Liaoning Yuhuang Pharmaceutical Bumetanide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Amneal Basic Information, Manufacturing Base and Competitors
Table 36. Amneal Major Business
Table 37. Amneal Bumetanide Product and Services
Table 38. Amneal Bumetanide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Sandoz Basic Information, Manufacturing Base and Competitors
Table 40. Sandoz Major Business
Table 41. Sandoz Bumetanide Product and Services
Table 42. Sandoz Bumetanide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Bumetanide Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Bumetanide Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Bumetanide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Bumetanide Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Bumetanide Production Site of Key Manufacturer
Table 48. Bumetanide New Entrant and Capacity Expansion Plans
Table 49. Bumetanide Mergers & Acquisitions in the Past Five Years
Table 50. Global Bumetanide Sales by Region (2017-2022) & (K Units)
Table 51. Global Bumetanide Sales by Region (2023-2028) & (K Units)
Table 52. Global Bumetanide Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Bumetanide Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Bumetanide Sales by Type (2017-2022) & (K Units)
Table 55. Global Bumetanide Sales by Type (2023-2028) & (K Units)
Table 56. Global Bumetanide Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Bumetanide Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Bumetanide Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Bumetanide Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Bumetanide Sales by Application (2017-2022) & (K Units)
Table 61. Global Bumetanide Sales by Application (2023-2028) & (K Units)
Table 62. Global Bumetanide Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Bumetanide Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Bumetanide Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Bumetanide Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Bumetanide Sales by Country (2017-2022) & (K Units)
Table 67. North America Bumetanide Sales by Country (2023-2028) & (K Units)
Table 68. North America Bumetanide Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Bumetanide Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Bumetanide Sales by Type (2017-2022) & (K Units)
Table 71. North America Bumetanide Sales by Type (2023-2028) & (K Units)
Table 72. North America Bumetanide Sales by Application (2017-2022) & (K Units)
Table 73. North America Bumetanide Sales by Application (2023-2028) & (K Units)
Table 74. Europe Bumetanide Sales by Country (2017-2022) & (K Units)
Table 75. Europe Bumetanide Sales by Country (2023-2028) & (K Units)
Table 76. Europe Bumetanide Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Bumetanide Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Bumetanide Sales by Type (2017-2022) & (K Units)
Table 79. Europe Bumetanide Sales by Type (2023-2028) & (K Units)
Table 80. Europe Bumetanide Sales by Application (2017-2022) & (K Units)
Table 81. Europe Bumetanide Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Bumetanide Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Bumetanide Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Bumetanide Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Bumetanide Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Bumetanide Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Bumetanide Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Bumetanide Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Bumetanide Sales by Application (2023-2028) & (K Units)
Table 90. South America Bumetanide Sales by Country (2017-2022) & (K Units)
Table 91. South America Bumetanide Sales by Country (2023-2028) & (K Units)
Table 92. South America Bumetanide Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Bumetanide Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Bumetanide Sales by Type (2017-2022) & (K Units)
Table 95. South America Bumetanide Sales by Type (2023-2028) & (K Units)
Table 96. South America Bumetanide Sales by Application (2017-2022) & (K Units)
Table 97. South America Bumetanide Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Bumetanide Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Bumetanide Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Bumetanide Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Bumetanide Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Bumetanide Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Bumetanide Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Bumetanide Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Bumetanide Sales by Application (2023-2028) & (K Units)
Table 106. Bumetanide Raw Material
Table 107. Key Manufacturers of Bumetanide Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Bumetanide Typical Distributors
Table 111. Bumetanide Typical Customers
List of Figures
Figure 1. Bumetanide Picture
Figure 2. Global Bumetanide Revenue Market Share by Type in 2021
Figure 3. Oral Drugs
Figure 4. Injection Drugs
Figure 5. Global Bumetanide Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Global Bumetanide Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Bumetanide Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Bumetanide Sales (2017-2028) & (K Units)
Figure 11. Global Bumetanide Price (2017-2028) & (US$/Unit)
Figure 12. Global Bumetanide Production Capacity (2017-2028) & (K Units)
Figure 13. Global Bumetanide Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Bumetanide Market Drivers
Figure 15. Bumetanide Market Restraints
Figure 16. Bumetanide Market Trends
Figure 17. Global Bumetanide Sales Market Share by Manufacturer in 2021
Figure 18. Global Bumetanide Revenue Market Share by Manufacturer in 2021
Figure 19. Bumetanide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Bumetanide Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Bumetanide Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Bumetanide Sales Market Share by Region (2017-2028)
Figure 23. Global Bumetanide Revenue Market Share by Region (2017-2028)
Figure 24. North America Bumetanide Revenue (2017-2028) & (USD Million)
Figure 25. Europe Bumetanide Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Bumetanide Revenue (2017-2028) & (USD Million)
Figure 27. South America Bumetanide Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Bumetanide Revenue (2017-2028) & (USD Million)
Figure 29. Global Bumetanide Sales Market Share by Type (2017-2028)
Figure 30. Global Bumetanide Revenue Market Share by Type (2017-2028)
Figure 31. Global Bumetanide Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Bumetanide Sales Market Share by Application (2017-2028)
Figure 33. Global Bumetanide Revenue Market Share by Application (2017-2028)
Figure 34. Global Bumetanide Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Bumetanide Sales Market Share by Type (2017-2028)
Figure 36. North America Bumetanide Sales Market Share by Application (2017-2028)
Figure 37. North America Bumetanide Sales Market Share by Country (2017-2028)
Figure 38. North America Bumetanide Revenue Market Share by Country (2017-2028)
Figure 39. United States Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Bumetanide Sales Market Share by Type (2017-2028)
Figure 43. Europe Bumetanide Sales Market Share by Application (2017-2028)
Figure 44. Europe Bumetanide Sales Market Share by Country (2017-2028)
Figure 45. Europe Bumetanide Revenue Market Share by Country (2017-2028)
Figure 46. Germany Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Bumetanide Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Bumetanide Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Bumetanide Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Bumetanide Revenue Market Share by Region (2017-2028)
Figure 55. China Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Bumetanide Sales Market Share by Type (2017-2028)
Figure 62. South America Bumetanide Sales Market Share by Application (2017-2028)
Figure 63. South America Bumetanide Sales Market Share by Country (2017-2028)
Figure 64. South America Bumetanide Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Bumetanide Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Bumetanide Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Bumetanide Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Bumetanide Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Bumetanide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Bumetanide in 2021
Figure 76. Manufacturing Process Analysis of Bumetanide
Figure 77. Bumetanide Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の三次元電気生理ナビゲーションシステム市場2022年：市場規模予測（～2028年）
  • 世界の血漿分画装置市場2022年：市場規模予測（～2028年）
  • 世界のヒト肝臓モデル市場2022年：市場規模予測（～2028年）
  • 世界のハイブリッド手首固定器市場2022年：市場規模予測（～2028年）
  • 世界の使い捨て型歯科滅菌針市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19199 )"世界のブメタニド市場2022年：市場規模予測（～2028年）" (英文：Global Bumetanide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。